Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04
Mark G. Carmichael, Linda C. Benavides, Jarrod P. Holmes, Jeremy D. Gates, Elizabeth A. Mittendorf, Sathibalan Ponniah, George E. PeoplesVolume:
116
Year:
2010
Language:
english
Pages:
10
DOI:
10.1002/cncr.24756
File:
PDF, 424 KB
english, 2010